Skip to main content

Erythromycin ethylsuccinate

HealthData.Gov

Updated Oct 29, 2026

About this dataset

Erythromycin Ethylsuccinate is an antibiotic used to treat bacterial infections. It's available as an oral suspension in strengths like 200 mg or 400 mg per 5 mL, packaged in 100 mL bottles. Manufactured by Cadila Pharmaceuticals Limited and Nivagen Pharmaceuticals, Inc., it's a prescription drug approved under ANDA216212. This information was generated using AI and is provided for informational and research purposes only.

Data and resources (1)

  • HTML

    Erythromycin ethylsuccinate

    Access the FDA dataset for Erythromycin ethylsuccinate — ANDA 061904 submitted by Mylan Institutional LLC

    Modified Oct 29, 2026

Prototype by Datopian · not an official government website · data from data.virginia.gov